A typical eukaryotic transcription unit contains an array of cis-acting elements positioned in close proximity to the transcription start site (nucleotide + 1), including the TATA box and initiator sequences, a variety of upstream regulatory signals positioned within 50 to 400 bp of the start site, and enhancer elements that may be located at great distances upstream or downstream of the start site (28) . A number of studies have suggested that DNA enhancer sequences, to a great extent, are responsible for temporal and tissue-specific gene expression (25) . Evidently, enhancer elements exert their activities by interacting with trans-acting protein factors. In this respect, it is well documented that the immunoglobulin heavy-chain gene and the polyomavirus and simian virus 40 enhancers possess several active motifs, each interacting with distinct cell-specific factors (7, 12, 35, 45) . Therefore, a gene can be selectively transcribed according to the relative abundance of these specific transcription factors and the particular arrangement of factor-binding sites present in its regulatory region.
Recent studies have indicated that transcription factors may participate in many developmental processes. Most of these proteins are capable of binding to DNA in a sequencespecific manner and are produced either in a variety of cell types during development, such as the Hox and Pax genes (9, 13) , and/or in particular cells and tissues, such as the pit-1, GATA-1, and myoD genes (23, 34, 47) . It has been estimated that more than 20,000 different genes are expressed in the mammalian nervous system, most of which are nerve specific and coordinately regulated during brain development (27) . However, the regulatory cascades and the participant factors in central nervous system (CNS) MBP is a major constituent of the myelin sheath, composing 30 to 40% of total myelin protein in the CNS (5) . This protein has several isoforms, ranging in size from 14 to 21.5 kDa (8, 30) , encoded by alternative splicing of a single major transcript from a single gene on mouse chromosome 18 (31) . MBP is expressed in a cell-type-specific manner. In the CNS, myelin formation and MBP gene expression occur in oligodendrocytes, whereas in the peripheral nervous system, Schwann cells are responsible for myelin formation and expression of the MBP gene. The developmental expression of MBP has been demonstrated by Northern (RNA) blot (36) and in situ hybridization (21, 44) techniques. Evidently, MBP transcripts first appear in brain tissue at 8 days postbirth in the mouse, peak at 18 days, and progressively decrease to about 20% of the peak level in the mature animal.
Transient transfection and in vitro transcription studies have been used by us (11) and others (29, 39) to identify cis-acting regulatory elements which participate in cell-typespecific expression of the MBP gene. These results have indicated that the MBP regulatory region is composed of multiple cis-acting elements, some of which stimulate transcription preferentially in CNS-derived cell lines. The proximal element, termed MB1, spans the sequences from -14 to -50 bp upstream of the transcription start site and has been shown to direct cell-type-specific transcription of a heterologous promoter (10, 11) . The sequences between -93 and -209 bp have been shown to contain multiple cell-typespecific elements (11) and a target sequence for the transcription factor NF1/CTF (17) . The most distal element, termed MB7, spans the sequences from -249 to -287 bp and activates transcription in many cell types (11) . Recent studies have also identified an element downstream from the transcription start site (+25 to +45 bp) which increases the 3104 HAAS ET AL.
transcriptional activity of the MBP gene in cell extracts derived from brain tissue (40) . The finding of multiple elements in the MBP promoter/enhancer region suggests that a complex pattern of regulatory sequences may be required for MBP gene expression. However, the biological relevance of these elements in vivo has not yet been established.
Recently, we have shown that the sequence spanning the MB1 region functions as a cell-type-specific enhancer element by transient transfection of CNS-derived cell lines (10) . In vitro transcription studies of the MBP promoter by others (42, 43) support the importance of this region in tissuespecific transcription. Because of its location with respect to the transcription start site, the MB1 element was initially thought to be involved in a direct interaction with basal transcription factors, e.g., TFIID. Sequence analysis of this region, however, indicates that the MB1 element does not contain a canonical TFIID binding site (TATAAA), and in vitro transcription studies suggest that its TATA-like motif (TTCAAA) may not participate in cell-type-specific transcription of the MBP promoter (43) . To understand the mechanism by which the MB1 element exerts its activity on brain-specific transcription of the MBP gene, protein purification, DNA binding, and in vitro transcription assays were used. Here, we report the identification and partial purification of a 38-to 41-kDa MB1-binding protein, derived from mouse brain tissue at the peak of myelination, which binds specifically to the MB1 element and activates transcription of the MBP gene in cell extract derived from HeLa cells. Of particular interest, we note that this protein is expressed in a tissue-specific and developmental stage-specific pattern which coincides with the pattern of MBP transcription in the developing mouse.
MATERIALS AND METHODS
Plasmids and oligonucleotides. Plasmids pMB402, pMB246, pMB164, and pMB86 contain fragments of the mouse MBP upstream regulatory region spanning the sequences from -402, -246, -164, and -86 bp upstream of the transcription start site, respectively, to +21 bp downstream. These fragments were amplified from the mouse genomic clone Pex-1 (gift from Arthur Roach) by polymerase chain reaction using the following upstream primers: 5'-AAAGCTTCCATGTA TACCAAGCAAGCT-3' (pMB402), 5'-AAAGC1TCAGGCC CACATTCATATCTC-3' (pMB246), 5'-AAAGCTFGGTGA GAGACTCCAAGCAC-3' (pMB164), and 5'-AAAGCTTCA ACTJ7GATCCGCCTCTTTT-3' (pMB86). The downstream primer for all constructs contains the following structural sequence: 5'-AGGTCCTGGGGTCTTCTITGGATGGTC-3'.
Amplimers were inserted into the HindIII-BamHI site of the promoterless reporter plasmid pBLCAT3 (24) , immediately upstream of the chloramphenicol acetyltransferase coding region. The integrity of the polymerase chain reactiongenerated inserts was confirmed by direct sequencing of the constructs. Plasmid pMB1320 was constructed by inserting a HindIII-AccI fragment of the MBP promoter, derived from Pex-1 (spanning the region from -1320 to -396 relative to the transcription start site), into the HindIII-AccI site of plasmid pMB402-
The following oligonucleotides were used as probes in DNA binding assays: 5'-AGGGAGGACAACACCTICAA AGACAGGCCCTCTGAG-3' (MB1) and 5'-GATCGATC GGGGCGGGGCGATC-3' (Spl). These sense-strand oligonucleotides were hybridized to complementary antisense strands, and double-stranded DNA was isolated by preparative polyacrylamide gel electrophoresis (PAGE).
Nuclear extract preparation. Nuclear extracts were prepared by a modification of the method of Wildeman et al. (46) . All procedures were carried out at 4°C. Briefly, fresh tissue was Dounce homogenized with 2 strokes of pestle B, washed with phosphate-buffered saline, and centrifuged for 5 min at 3,000 rpm. The tissue pellet was resuspended in 4 volumes of buffer A containing 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol (DTT), and 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and incubated for 15 min on ice. The suspension was again Dounce homogenized with 10 to 20 strokes of pestle B and centrifuged for 30 min at 10,000 rpm. The pellet was resuspended in 4 volumes of buffer B containing 20 mM HEPES (pH 7.9), 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, and 25% (vol/vol) glycerol and incubated for 15 min on ice. Following centrifugation for 30 min at 10,000 rpm, the supernatant was precipitated with (NH4)2SO4 (0.33 g/ml). The pellet was resuspended in a minimal volume of buffer D containing 10 mM HEPES (pH 7.9), 100 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.5 mM PMSF, and 17% (vol/vol) glycerol and dialyzed against two changes, 50 volumes each, of the same buffer. The total protein concentration in the extract was typically 5 to 10 mg/ml, as measured by the method of Bradford (3) . The integrity of the extracts was examined by sodium dodecyl sulfate (SDS)-
PAGE.
Band shift assay and UV cross-linking. Oligonucleotide probes were prepared by end labeling of commercially synthesized oligonucleotides with [y-32P]ATP and T4 polynucleotide kinase (2) . DNA-protein complexes were allowed to form during incubation of the protein sample with 20,000 to 100,000 cpm of probe DNA in a 30-,ul reaction mixture containing 1.5 ,ug of poly(dI-dC), 12 mM HEPES (pH 7.9), 4 mM Tris (pH 7.5), 60 mM KCI, 5 mM KCl2, and 0.8 mM DTT. The reaction mixture was incubated for 20 min on ice. For competition, the binding mixture was preincubated with unlabeled competitor oligonucleotides for 10 min on ice, and then the reaction was carried out as described above.
In band shift studies, the complexes were resolved by electrophoresis on a low-ionic-strength (0.5x Tris-borate-EDTA) 9% native polyacrylamide gel. Gels were fixed in 10% methanol-10% acetic acid and dried on 3MM paper (Whatman), and complexes were detected by autoradiography. Band intensities were quantitated by PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.) scanning (19) proteins were eluted with gentle shaking overnight at room temperature in 2.0 ml of elution buffer containing 50 mM Tris (pH 7.9), 0.1% SDS, 150 mM NaCl, 0.1 mM EDTA, 5 mM DTT, and 0.1 mg of bovine serum albumin (BSA) fraction V per ml. Gel pieces were pelleted by centrifugation at 4,000 rpm for 15 min. The supernatant was collected, and eluted proteins were precipitated with 8.0 ml of cold acetone (-20°C) on dry ice for 30 min. Precipitated proteins were collected by centrifugation at 10,000 rpm for 30 min; allowed to air dry for 10 min at room temperature; resuspended in 20 ,ul of dilution buffer containing 50 mM Tris (pH 7.9), 150 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.1 mg of BSA fraction V per ml, and 20% (vol/vol) glycerol supplemented with 6 M guanidine HCl; and incubated for 30 min at room temperature; 1.0 ml of dilution buffer was then added, and the proteins were permitted to renature overnight at room temperature. Renatured proteins were stored at -80°C.
Chromatography. All chromatographic procedures were carried out at 4°C. Nuclear extract, prepared as described above from the brain tissue of 200 mice, 18 days postbirth, was applied to a 60-ml phosphocellulose (Whatman P11) column equilibrated with buffer D containing 10 mM HEPES (pH 7.9), 100 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.5 mM PMSF, and 10% (vol/vol) glycerol. The column was washed with this buffer until the A280 of the eluate reached baseline. The column was eluted with a linear gradient of 0.1 to 0.8 M KCI in the same buffer. Fractions containing peak DNA-binding activity were pooled; dialyzed against buffer E containing 10 mM Tris (pH 7.5), 50 mM KCI, 5 mM MgCl2, 0.5 mM DTT, 0.5 mM PMSF, and 10% (vol/vol) glycerol; and applied to a 5-ml DEAE-Sephacel (Pharmacia) column equilibrated with the same buffer. The column was washed with this buffer until the A280 of the eluate reached baseline and then eluted with a linear gradient of 0.05 to 0.75 M KCI in buffer E. Peak fractions were pooled and assayed for DNA-binding activity by band shift assay and for protein concentration by the Bradford method (3).
In vitro transcription assay. Whole cell extract was prepared from HeLa cells grown in suspension culture in minimal essential medium (Quality Biochemical) supplemented with 5% horse serum as described by Manley et al. (26) . Template DNA was prepared by EcoRI (pMB1320, pMB402, pMB246, pMB164, and pMB86) or SphI (pBjc; described in reference 1) digestion to generate runoff transcripts of 298 (pMB1320, pMB402, pMB246, pMB164, and pMB86) or 450 (pBjc) nucleotides. Transcription reactions in mixtures of 15 ,ul containing 0.1 Fg (pMB1320, pMB402, pMB246, pMB164, and pMB86) or 0.2 ,ug (pBjc) of template DNA, 6 pl of HeLa whole cell extract, 20 ,uCi of [a-32PJUTP (400 Ci/mmol; Amersham), 1.3 mM ATP, 1.3 mM CTP, 1.3 mM GTP, and 33 p,g of poly(dI-dC) per ml were carried out in a buffer containing 20 mM HEPES (pH 7.9), 100 mM KCl, 12.5 mM MgCl2, 0.1 mM EDTA, 2 mM DTT, and 17% (vol/vol) glycerol. Runoff transcripts were analyzed on a denaturing 6% polyacrylamide gel and detected by autoradiography. Transcriptional activities were quantitated by PhosphorImager (Molecular Dynamics) scanning (19) of the dried gels and/or laser densitometry of autoradiograms.
Northern blot analysis. Total RNA was isolated from mouse tissue by the guanidine isothiocyanate method (6) . RNA samples (20 p,g) were separated on a 1% agarose-6.6%
formaldehyde slab gel, transferred to nitrocellulose as described by Southern (37) , and heated to 80°C for 2 
RESULTS
Developmental and tissue-specific distribution of MBl-binding protein. Previously, we have demonstrated that mouse brain nuclear extract contains proteins which specifically bind to the sequences corresponding to the MB1 region of the MBP promoter (22) . To examine the developmental distribution of MB1-binding proteins in mouse brain, band shift assays using double-stranded MB1 oligonucleotide DNA were used to probe nuclear extracts prepared from mouse brain tissue at different stages during development. In this study, we used 10 ,ug of nuclear extracts derived from mouse brain at 3, 7, 18, 30, and >60 (adult) days postbirth.
These ages were chosen because MBP transcription starts at 8 to 10 days postbirth, peaks at 18 days, and decreases to 20% of peak levels in the adult (21, 36, 44) . Three DNA protein complexes, designated A, B, and C, were identified in mouse brain nuclear extract (Fig. 1A) . Apparently, the protein(s) associated with complex A is constitutively expressed during brain development, with approximately equal abundance at all ages. From the intensity of the band corresponding to complex B, it appears that the level of participant proteins in the B complex is low in the brain prior to the onset of myelination, i.e., 3 and 7 days postbirth, greatly increases in 18 days, and persists at a relatively high VOL. 13, 1993 on level in older (30 days) and adult mice. Complex C was observed only in extract derived from brain tissue at or after the peak of myelination, i.e., from mice at 18 days postbirth or from older mice. These results indicate that proteins involved in the formation of complexes B and C are expressed during development in a pattern which correlates well with the developmental pattern of MBP transcription. These observations confirm our earlier results (22) suggesting that the MB1-binding proteins in the brain are developmentally expressed. Extracts were also assayed for Spl, a sequence-specific DNA-binding protein and transcription factor (4) whose mRNA is expressed at relatively constant levels in the murine cerebrum throughout development (33) . As expected, Spl-binding activity remains constant throughout brain development (Fig. 1B) . From these results, we conclude that enhanced MB1-binding activity during development does not result from a general developmental increase in transcription factor expression but rather is specific to MB1-binding activity. Figure 1C Since MBP transcription is restricted to nervous system tissue, we examined whether the MB1-binding proteins were likewise expressed only in this tissue. Therefore, a panel of nuclear extracts derived from the brain, heart, kidney, liver, and spleen of mice at 18 days postbirth was prepared and screened for the presence of MB1-binding proteins in a band shift assay. As shown in Fig. 1D , a complex comigrating with complex A was detected in all tissues. In heart and kidney extracts, a complex similar in electrophoretic mobility to the B complex of brain, but with a reduced intensity, was detected. Complex C was observed only in brain extract. Again, the B and C complexes were detected at greatest abundance in the 18-day brain extract. Bands with mobilities faster than that of complex A were seen in all tissues. These bands were determined to be nonspecific on the basis of competition with unlabeled oligonucleotides (data not shown). Figure 1E demonstrates tissue distribution of MBP transcripts that correlate with the abundance of the B and C complexes in various tissues.
Localization of the binding site within the MB1 element and specificity of the DNA-protein complex. To critically identify the DNA sequences required for the formation of the three complexes, competition experiments were performed with various competitor DNAs derived from the MB1 region ( Fig.  2A) . The synthetic competitor DNAs were constructed such that they divide the MB1 element into three overlapping and nonoverlapping regions. As shown in Fig. 2B , MB1 and MB1A oligonucleotides effectively compete for the formation of all three complexes, whereas MB1C competes much less efficiently than do MB1 and MB1A. The MB1K oligonucleotide appears to compete only for the formation of the A complex. In summary, the affinity of complexes B and C for these DNAs can be described as MB1 = MB1A > MB1C > > MB1K. Complex A, however, binds efficiently to each of these DNAs. These observations suggest that the MB1A oligonucleotide contains the full binding site for complexes B and C, so that at least part of the binding site must be found between -14 and -28 bp. This region of the MB1 element has previously been shown to participate in brain-specific transcription of the MBP promoter in vitro (43) , such that the binding site specificity of the B and C complexes is consistent with a role for these complexes in transcription of the MBP gene. Furthermore, complexes B and C bind specifically to the MB1 DNA sequence, since they can be competed for with homologous MB1 DNA but not with MB1K DNA. Complex A was competed for efficiently with all four competitor DNAs, suggesting that either the participant protein(s) binds the central region of the MB1 DNA, which is conserved in all four competitors, or the formation of this complex is not sequence specific.
UV cross-linking analysis of MB1 complexes. To determine the relative molecular weights of the A, B, and C complexes, UV cross-linking of the proteins with the specific target sequences was performed. In this study, the labeled MB1 fragment was incubated with 18-day-postbirth brain extract, cross-linked by UV irradiation, and resolved by SDS-PAGE. A major nucleoprotein band of 56 to 60 kDa and a minor band of 32 kDa were detected by autoradiography (Fig. 3,  lane 1) .
To more specifically identify the molecular weight of each of the complexes observed in the band shift assay, the DNA-protein complexes A, B, and C were cross-linked and then resolved on a native polyacrylamide gel (Fig. 3, lane 2) . Bands corresponding to each complex were excised, and their protein contents were separately analyzed by SDS-PAGE. Complex A migrated between 56 and 58 kDa (Fig. 3,  lane 3) . Complexes B and C both migrated as single broad bands of 56 to 60 kDa (Fig. 3, lanes 4 and 5) . The results of this experiment demonstrate that all three complexes contain a DNA-binding protein which forms a DNA-protein complex that migrates with an apparent molecular mass of 56 to 60 kDa. Since the bands observed here correspond to covalently linked DNA-protein complexes, it is important to note that the protein component of these complexes would be expected to have a molecular weight lower than that detected by this method.
Partial purification of the MB1 binding protein from mouse brain nuclear extract. To examine the biological activity of the MB1-binding protein and its role in transcription of the MBP promoter, the MB1-binding protein was partially purified by conventional column chromatography. To this end, nuclear extract was prepared from the brain of 18-daypostbirth mice and fractionated on P11 phosphocellulose. Proteins were collected from the column by a linear gradient of KCI from 100 to 800 mM (Fig. 4A) . Band shift assay suggested that the peak of MB1-binding activity, consisting of the proteins that form complexes B and C, was eluted from 350 to 650 mM KCl (Fig. 4B) . In this fractionation, proteins that constitute complex A were eluted at a lower salt concentration. Fractions containing the highest level of MB1 activity were pooled, and quantitative measurement of their binding activity revealed that the MB1-binding protein was purified approximately 10-fold.
The pooled fractions from the P11 column were enriched in the B and C complexes and depleted of the A complex. The pooled P11 fractions were subsequently fractionated by DEAE-Sephacel chromatography. The DEAE-Sephacel column was eluted with a linear gradient of 50 to 750 mM KCl, and peak MB1-binding activity was obtained in fractions between 250 and 500 mM KCI (Fig. 4C ). This step allowed a further 2-fold purification of the MB1-binding activity, such that the activity was enriched about 20-fold relative to crude nuclear extract. pMB1320, pMB402, pMB246, pMB164, and pMB86 (Fig. 5A ),
were linearized with the endonuclease EcoRI, thus cleaving these DNAs 298 bp downstream from the major MBP RNA start site (20, 38) . A major transcript 298 nucleotides in length is observed ( Fig. 5B and C, 6C, and 7B), consistent with faithful initiation of transcription from the MBP promoter/enhancer in HeLa cell extract. As shown in Fig. 5B Fig. 6B demonstrate that proteins derived from slice 9, with electrophoretic mobilities between 38 and 41 kDa, contain binding activity to the MB1 oligonucleotide. Although the DEAE fraction contained both the B and C complexes, activity of only one complex, with an electrophoretic mobility similar to that of complex C, was restored during the renaturation process.
To examine the transcriptional activity of the gel-purified MB1-binding proteins, supplementation experiments using proteins derived from slices 8, 9, and 10 were performed. The ability of HeLa extract to transcribe the MBP promoter was substantially increased when proteins from slice 9, but not from slice 10, were included in the reaction mixture. A low but detectable level of enhancement was obtained upon addition of proteins from slice 8 to the HeLa extract as well, suggesting that this fraction may contain a low level of the activator protein, enough to exert its transcriptional activity but not sufficient to be detected by binding assay. The maximal stimulation of transcription with lower concentrations of renatured proteins suggests squelching of transcriptional activation when excess amounts of these factors are introduced into the system. These data suggest that a 38-to 41-kDa brain-specific DNA-binding protein, in concert with other basal transcription factors present in HeLa cells, increases transcription of the oligodendrocyte-specific MBP promoter in the nonbrain extract. Competition analysis confirms the role of the MB1-binding protein in transcriptional activation. To identify the critical nucleotides within the MB1 sequence which participate in binding of the MBl-binding protein, competition analysis using wild-type and mutant oligonucleotides was performed (Fig. 7A) . The wild-type MB1A oligonucleotide completely abrogated formation of complexes with the MB1 DNA probe (see also Fig. 2 ), whereas the mutant MBldlA oligonucleotide had no effect on the assembly of the MB1 complexes. Comparison of these sequences reveals that three base pairs are mutated in the MBldlA sequence, thus identifying these as the base pairs required for binding of the MB1-binding protein to its target sequence.
The role of this protein in transcriptional activation of the MBP promoter/enhancer was examined in an in vitro supplementation/transcription assay, using these oligonucleotides to specifically compete for the MB1-binding protein.
As shown in Fig. 7B and C 
DISCUSSION
We have previously used Southwestern (DNA-protein) blot analysis to identify 37-and 39-kDa proteins derived from mouse brain tissue which bind the MB1A oligonucleotide (22) . The abundance of these proteins varies developmentally, with the 39-kDa protein abundant in newborn (3-day) and young (18-to 30 -day) mouse brain and the 37-kDa protein abundant in adult mouse brain. The binding site specificities and molecular weights of these proteins suggest that they may be related, if not identical, to the protein described here. We have also previously identified two distinct MB1-binding proteins present in extract of CNS-derived cell lines (10) . However, these apparently differ from the brain-derived MB1-binding protein, since they have a different binding site specificity within the MB1 region. In contrast to the cell line-derived proteins, the brain-derived MB1-binding protein is a potential candidate for a functionally relevant MBP transcription factor as a result of its tissue-specific and developmental stage-specific accumulation.
UV cross-linking analysis has demonstrated that the developmentally regulated (complexes B and C) and constitutively expressed (complex A) MB1-binding factors contain proteins with similar molecular weights. These data raise the possibility that these complexes may result from tissuespecific and developmentally regulated modifications of a single protein. 16) , and glycosylation of transcription factors has also been reported (18) . However, the possibility remains that these proteins are unrelated and that their similarity in molecular weight is coincidental. The nature and extent of posttranslational modifications to these proteins are interesting questions which remain to be answered.
Transient transfection experiments have shown that the MB1 element has characteristics of a cell-type-specific enhancer, yet the location of this element relative to the transcriptional start site (-14 to -50 bp) and the presence of the TATA-like sequence motif TTCAAA within the enhancer suggest that the MB1 element may function to establish a basal level of transcription by interacting with general transcriptional machinery. Indeed, the fractionation scheme used here is similar, though not identical, to reported procedures for TFIID purification. Though the MB1-binding protein migrates in SDS-PAGE with an apparent molecular mass of 38 to 41 kDa, similar to that reported for mammalian TFIID (35 to 38 kDa) (15, 41) , several lines of evidence argue against the possibility that this factor is identical to TFIID. Band shift analysis has shown that the MB1-binding protein binds the MBP promoter downstream of the TTCAAA motif. Likewise, Tamura et al. (42, 43) have shown by extensive mutational analysis that brain-specific transcription of the MBP proximal promoter is governed by a brain-specific TFIID-like factor which functions through sequences downstream from the dispensable TTCAAA motif. The binding site specificity of this factor suggests that it differs from previously characterized mouse TFIID. Furthermore, our results indicate that the MB1-binding protein stimulates transcription of the MBP promoter, but not a neurotropic viral promoter (JCVE), suggesting a more specific role for this protein in enhancing brain-specific promoter activity. Further analysis of this regulatory protein, including comparison with the well-characterized general transcription machinery (reviewed in reference 32), awaits purification of this factor to homogeneity and subsequent cDNA cloning and DNA sequence analysis. These proposed experiments, currently ongoing in our laboratory, should elucidate the role of the MB1-binding protein in transcription of the MBP gene.
